Publications by authors named "Maria Key Prato"

Claim this Profile
O
Optimizing the MDS-UPDRS Part III for early-stage Parkinson's: early supportive evidence for a limb-related bradykinesia/rigidity sub-score.
Antoine Regnault, Maria Key Prato, Stéphane Quéré, Anne Benoit, Nathalie J Massat

NPJ Parkinsons Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Matters Arising: In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson's disease.
Diana L Price, Asma Khan, Rachel Angers, Alvaro Cardenas, Maria Key Prato

NPJ Parkinsons Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson's disease.
Diana L Price, Asma Khan, Rachel Angers, Alvaro Cardenas, Maria Key Prato

NPJ Parkinsons Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/1b Studies of UCB0599, an Oral Inhibitor of α-Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease.
Johan Willem Smit, Peter Basile, Maria Key Prato, Laurent Detalle, François-Xavier Mathy

Mov Disord· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hamster neogenin, a host-cell protein contained in a respiratory syncytial virus candidate vaccine, induces antibody responses in rabbits but not in clinical trial participants.
Ann-Muriel Steff, Chanel Cadieux-Dion, Gaël de Lannoy, Maria Key Prato, Xavier Czeszak

Hum Vaccin Immunother· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis